Company: MIRA
Filing Date: 2025-08-08
Form Type: DEFM14A
Source: 0001641172-25-022816
Chunk: 4

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-08-08
Form: DEFM14A
Chunk 4
---
------------------------------------------------------------------------------------------------------------------------------------|
| 5. | approve                                                                                                                             
 a postponement or adjournment of the Merger virtual annual meeting, if necessary, to solicit additional proxies if there are not    
 sufficient votes in favor of Proposal No. 1 (the “Adjournment Proposal” or “Proposal No. 5”).                                       |

Please refer to the attached proxy statement for further information with respect to the business to be transacted at the MIRA virtual annual meeting. The board of directors of MIRA (the “MIRA Board”) has fixed July 21, 2025, as the record date for the determination of stockholders entitled to notice of, and to vote at, the MIRA virtual annual meeting and any adjournment or postponement thereof. Only holders of record of shares of MIRA Common Stock at the close of business on the record date are entitled to notice of, and to vote at, the MIRA virtual annual meeting. At the close of business on the record date, MIRA had 19,069,315 shares of MIRA Common Stock outstanding and entitled to vote. A complete list of such stockholders entitled to vote at the MIRA virtual annual meeting will be available for examination at the MIRA offices in Miami, Florida during normal business hours for a period of ten days prior to the MIRA virtual annual meeting.

Your vote is important. Approval of Proposal Nos. 1, 3, 4 and 5 requires the affirmative vote of a majority of the votes cast virtually or by proxy at the MIRA virtual annual meeting and for Proposal No. 2, the five Company nominees receiving the highest number of affirmative votes will be elected directors of the MIRA. Proposal No. 1 is a condition to the consummation of the Merger. Therefore, the Merger cannot be consummated without the approval of Proposal No. 1.

You are cordially invited to attend the MIRA virtual annual meeting. Whether or not you expect to attend the meeting, you are urged to cast your vote as soon as possible. You may vote your shares via the internet or via a toll-free telephone number by following the instructions on the enclosed proxy card. In addition, if you received paper copies of the proxy materials by mail, you can also vote by mail by following the instructions on the enclosed proxy card. Submitting a proxy card will not prevent you from attending the MIRA virtual annual meeting and voting at the MIRA virtual annual meeting if you so desire. Please note, however, that